Effect of pneumococcal conjugate vaccination on radiological findings in infants hospitalized with community acquired pneumonia in northern India

Effect of pneumococcal conjugate vaccination on radiological findings in infants hospitalized with community acquired pneumonia in northern India

Bibliographic Details
Main Authors:	S. Awasthi, C. Mani Pandey, T. Verma, N. Mishra, R. Chandra Shukla, N. Mohindra, A. Chauhan, M. Agarwal, N. Kohli, C. Study Group
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220311437

Similar Items

Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India
by: Shally Awasthi, et al.
Published: (2022-01-01)

Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India.
by: Shally Awasthi, et al.
Published: (2022-01-01)

Incidence of community acquired pneumonia in children aged 2-59 months of age in Uttar Pradesh and Bihar, India, in 2016: An indirect estimation.
by: Shally Awasthi, et al.
Published: (2019-01-01)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
by: Cornelis H. van Werkhoven
Published: (2017-05-01)

Effectiveness of 7-valent pneumococcal conjugate vaccine against radiologically diagnosed pneumonia in indigenous infants in Australia
by: KF O'Grady, et al.
Published: (2010-02-01)

Incidence of pneumonia is not reduced by pneumococcal conjugate vaccine
by: Sona Chowdhary, et al.
Published: (2008-10-01)

Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
by: Vincenzo Baldo, et al.
Published: (2016-01-01)

Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis
by: Silaba, M, et al.
Published: (2019)

Pneumococcal colonisation and pneumonia severity in hospitalised Cambodian children following introduction of the 13-valent pneumococcal conjugate vaccine
by: Miliya, T, et al.
Published: (2023)

To assess the effectiveness of various communication strategies for improving childhood pneumonia case management: study protocol of a community based behavioral open labeled trial in rural Lucknow, Uttar Pradesh, India
by: Shally Awasthi, et al.
Published: (2018-08-01)

Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
by: Grossi Paolo, et al.
Published: (2005-11-01)

Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
by: Ching-Fen Shen, et al.
Published: (2021-09-01)

Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis
by: Micah Silaba, MMed, et al.
Published: (2019-03-01)

Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
by: Gili Regev-Yochay, et al.
Published: (2018-10-01)

Pneumococcal aetiology and serotype distribution in paediatric community-acquired pneumonia.
by: Iris De Schutter, et al.
Published: (2014-01-01)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
by: Chiara Scelfo, et al.
Published: (2021-04-01)

Pneumococcal conjugate vaccine is efficacious and effective in reducing the burden of pneumonia
by: Shabir A Madhi, et al.
Published: (2008-10-01)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
by: Lucía Fernández-Delgado, et al.
Published: (2021-10-01)

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
by: Andrew D. Wiese, et al.
Published: (2019-04-01)

Effectiveness of various communication strategies for improving childhood pneumonia case management: a community based behavioral open labeled trial in rural Lucknow, Uttar Pradesh, India
by: Shally Awasthi, et al.
Published: (2019-12-01)

Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation
by: Ezgi Demirdogen Cetinoglu, et al.
Published: (2017-09-01)

Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
by: Hong-Yi Lee, et al.
Published: (2018-04-01)

Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines.
by: Thomas Benfield, et al.
Published: (2013-01-01)

Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
by: Irina Kislaya, et al.
Published: (2019-01-01)

Changes in the pneumococcal vaccine serotypes in adult noninvasive pneumonia after the introduction of pneumococcal conjugate vaccination for children
by: Hiroaki Takeda, et al.
Published: (2019-01-01)

EVALUATION OF THE EFFECTIVENESS OF PNEUMOCOCCAL VACCINES FOR PREVENTION OF COMMUNITY-ACQUIRED PNEUMONIA IN SERVICEMEN
by: S. D. Zhogolev, et al.
Published: (2018-12-01)

Prognostic value of pneumococcal urinary antigen test in community-acquired pneumonia.
by: Byunghyun Kim, et al.
Published: (2018-01-01)

Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae
by: Allison E.B. Turner, et al.
Published: (2017-03-01)

STREPTOCOCCUS PNEUMONIAE SEROTYPE DISTRIBUTION AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINES
by: Mariya Malcheva
Published: (2019-06-01)

High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
by: Swarthout, TD, et al.
Published: (2020)

Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015).
by: Andreia N Horácio, et al.
Published: (2018-01-01)

PECULIARITIES OF THE PNEUMOCOCCAL PNEUMONIAE IN CHILDREN
by: T. A. Daminov, et al.
Published: (2015-08-01)

Upregulated pneumococcal adhesion molecule (platelet-activating factor receptor) may predispose COPD patients to community-acquired pneumonia
by: Shukla SD, et al.
Published: (2017-10-01)

Severe Streptococcus pneumoniae 19A pneumonia with empyema in children vaccinated with pneumococcal conjugate vaccines
by: Chun-Yi Lu, et al.
Published: (2015-08-01)

Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.
by: Andreia N Horácio, et al.
Published: (2014-01-01)

Health related quality of life in patients with community-acquired pneumococcal pneumonia in France
by: Luiz Flavio Andrade, et al.
Published: (2018-02-01)

Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines
by: Andrew D. Wiese, et al.
Published: (2016-06-01)

Pneumococcal conjugate vaccine is effective against hypoxic pneumonia in Laos, Mongolia and Papua New Guinea
by: Nguyen, C, et al.
Published: (2021)

Nasopharyngeal colonization of Gambian infants by Staphylococcus aureus and Streptococcus pneumoniae before the introduction of pneumococcal conjugate vaccines
by: E. Usuf, et al.
Published: (2016-03-01)

Evaluation of acute and convalescent antibody concentration against pneumococcal capsular polysaccharides for the diagnosis of pneumococcal infection in children with community-acquired pneumonia
by: Carter, MJ, et al.
Published: (2024)